Brian Powl - Chief Commercial Officer at FATE THERAPEUTICS INC

Insider Transactions and Holdings

Entity Type
Individual
Role
Chief Commercial Officer
Issuer Symbol
FATE on Nasdaq
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Brian Powl since 11 Jan 2025

Holdings reported by Brian Powl for FATE THERAPEUTICS INC

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Stock Option (Right to Buy) 425,000 $1,160,250 $2.73 06 Feb 2023 Direct Common Stock
Common Stock 41,146 $179,808 $4.37 05 Jul 2023 Direct

Transactions reported by Brian Powl for FATE THERAPEUTICS INC

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.